Shenzhen Techwinsemi Technology (001309.SZ)'s application for additional stock issuance has been approved by the Listing Review Center of the Shenzhen Stock Exchange.
Techwinsemi (001309.SZ) announced that on September 18, 2026, the company received the "Notification Letter of the Review Center Opinions on the Application of Shenzhen Techwinsemi Technology Co., Ltd. for Issuing Shares to Specific Targets" issued by the Shenzhen Stock Exchange. The Listing Review Center of the Shenzhen Stock Exchange reviewed the company's application documents for issuing shares to specific targets and considered that the company meets the issuance conditions, listing conditions, and information disclosure requirements. Subsequently, the Shenzhen Stock Exchange will, in accordance with regulations, submit the matter to the China Securities Regulatory Commission (hereinafter referred to as the "CSRC") to carry out the relevant registration procedures.
Shenzhen Techwinsemi Technology (001309.SZ) announced that on September 18, 2026, the company received the "Notification Letter of the Listing Review Center Opinion on the Application of Shenzhen Techwinsemi Technology Co., Ltd. for Issuing Shares to Specific Targets" issued by the Shenzhen Stock Exchange. The Listing Review Center of the Shenzhen Stock Exchange reviewed the company's application documents for issuing shares to specific targets and considered that the company meets the issuance conditions, listing conditions, and information disclosure requirements. Subsequently, the Shenzhen Stock Exchange will, in accordance with regulations, submit the matter to the China Securities Regulatory Commission (hereinafter referred to as the "CSRC") to carry out the relevant registration procedures.
Related Articles
Beijing Huayuan Xinhang Holding (600743.SH)'s controlling shareholder is proposed to be changed to Financial Street Holdings Capital.
Anhui Honglu Steel Construction (002541.SZ) subsidiary signs major business contract, with an estimated contract value of approximately 280 million yuan.
Beijing Beilu Pharmaceutical (300016.SZ) obtained the drug registration certificate for Bimatoprost Eye Drops.
Beijing Huayuan Xinhang Holding (600743.SH)'s controlling shareholder is proposed to be changed to Financial Street Holdings Capital.
Anhui Honglu Steel Construction (002541.SZ) subsidiary signs major business contract, with an estimated contract value of approximately 280 million yuan.
Beijing Beilu Pharmaceutical (300016.SZ) obtained the drug registration certificate for Bimatoprost Eye Drops.
RECOMMEND
